10-93601831-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1
The ENST00000604414.1(FFAR4):c.697-2243C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.161 in 571,988 control chromosomes in the GnomAD database, including 8,772 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.14 ( 1680 hom., cov: 33)
Exomes 𝑓: 0.17 ( 7092 hom. )
Consequence
FFAR4
ENST00000604414.1 intron
ENST00000604414.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.146
Publications
30 publications found
Genes affected
FFAR4 (HGNC:19061): (free fatty acid receptor 4) This gene encodes a G protein-coupled receptor (GPR) which belongs to the rhodopsin family of GPRs. The encoded protein functions as a receptor for free fatty acids, including omega-3, and participates in suppressing anti-inflammatory responses and insulin sensitizing. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2012]
RBP4 (HGNC:9922): (retinol binding protein 4) This protein belongs to the lipocalin family and is the specific carrier for retinol (vitamin A alcohol) in the blood. It delivers retinol from the liver stores to the peripheral tissues. In plasma, the RBP-retinol complex interacts with transthyretin which prevents its loss by filtration through the kidney glomeruli. A deficiency of vitamin A blocks secretion of the binding protein posttranslationally and results in defective delivery and supply to the epidermal cells. [provided by RefSeq, Jul 2008]
RBP4 Gene-Disease associations (from GenCC):
- progressive retinal dystrophy due to retinol transport defectInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P
- microphthalmia, isolated, with colobomaInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: G2P, Orphanet
- microphthalmia, isolated, with coloboma 10Inheritance: AD, AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- isolated anophthalmia-microphthalmia syndromeInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.24).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.316 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RBP4 | NM_001323518.2 | c.-115G>A | upstream_gene_variant | NP_001310447.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FFAR4 | ENST00000604414.1 | c.697-2243C>T | intron_variant | Intron 2 of 2 | 3 | ENSP00000474477.1 | ||||
| RBP4 | ENST00000371467.5 | c.-488G>A | upstream_gene_variant | 5 | ENSP00000360522.1 | |||||
| RBP4 | ENST00000371469.2 | c.-115G>A | upstream_gene_variant | 5 | ENSP00000360524.2 |
Frequencies
GnomAD3 genomes AF: 0.137 AC: 20767AN: 152062Hom.: 1681 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
20767
AN:
152062
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.170 AC: 71326AN: 419808Hom.: 7092 AF XY: 0.179 AC XY: 40803AN XY: 227394 show subpopulations
GnomAD4 exome
AF:
AC:
71326
AN:
419808
Hom.:
AF XY:
AC XY:
40803
AN XY:
227394
show subpopulations
African (AFR)
AF:
AC:
757
AN:
10564
American (AMR)
AF:
AC:
3075
AN:
24460
Ashkenazi Jewish (ASJ)
AF:
AC:
3388
AN:
14434
East Asian (EAS)
AF:
AC:
2059
AN:
24384
South Asian (SAS)
AF:
AC:
14011
AN:
45560
European-Finnish (FIN)
AF:
AC:
3122
AN:
30254
Middle Eastern (MID)
AF:
AC:
600
AN:
2824
European-Non Finnish (NFE)
AF:
AC:
40412
AN:
244220
Other (OTH)
AF:
AC:
3902
AN:
23108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
2689
5378
8066
10755
13444
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
200
400
600
800
1000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.137 AC: 20793AN: 152180Hom.: 1680 Cov.: 33 AF XY: 0.139 AC XY: 10318AN XY: 74396 show subpopulations
GnomAD4 genome
AF:
AC:
20793
AN:
152180
Hom.:
Cov.:
33
AF XY:
AC XY:
10318
AN XY:
74396
show subpopulations
African (AFR)
AF:
AC:
2842
AN:
41542
American (AMR)
AF:
AC:
2311
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
808
AN:
3470
East Asian (EAS)
AF:
AC:
473
AN:
5174
South Asian (SAS)
AF:
AC:
1585
AN:
4814
European-Finnish (FIN)
AF:
AC:
1012
AN:
10580
Middle Eastern (MID)
AF:
AC:
75
AN:
294
European-Non Finnish (NFE)
AF:
AC:
11259
AN:
67986
Other (OTH)
AF:
AC:
372
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
937
1874
2812
3749
4686
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
242
484
726
968
1210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
602
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.